Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
44
Number of overlapping holdings
34.1%
% of BMED's 147 holdings also in BTEC
20.6%
% of BTEC's 220 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus BTEC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in BTEC |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 1.6% | 2.3% | 1.6% |
|
SAREPTA THERAPEUTICS INC | 1.4% | 2.6% | 1.4% |
|
BLUEPRINT MEDICINES CORP. | 1.5% | 1.4% | 1.4% |
|
ELANCO ANIMAL HEALTH, INC. | 1.1% | 1.8% | 1.1% |
|
NUVALENT, INC. CLASS A | 1.0% | 1.1% | 1.0% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to BTEC
|
BOSTON SCIENTIFIC CORP | 3.5% |
|
AMERISOURCEBERGEN CORP | 3.1% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
COOPER COS INC/THE | 2.1% |
 |
NOVO NORDISK A/S-B | 2.1% |
|
ABBVIE INC | 2.1% |
|
ALIGN TECHNOLOGY INC | 2.0% |
|
WEST PHARMACEUTICAL SERVICES | 2.0% |
|
AMGEN INC | 1.9% |
|
BIOMARIN PHARMACEUTICAL INC | 1.8% |
BMED Underweight Relative to BTEC
|
KARUNA THERAPEUTICS, INC. | -2.4% |
|
NATERA INC | -2.3% |
|
EXACT SCIENCES CORP | -2.2% |
|
ILLUMINA INC | -2.0% |
|
BIO-RAD LABORATORIES-CL A | -1.9% |
|
CYTOKINETICS INC | -1.7% |
|
INTRA-CELLULAR THERAPIES INC | -1.6% |
|
APELLIS PHARMACEUTICALS, INC. | -1.5% |
|
BRIDGEBIO PHARMA, INC. | -1.3% |
|
SAREPTA THERAPEUTICS INC | -1.2% |